AVTR Stock Forecast: Avantor, Inc. Price Predictions for 2026-2027
The 15 Wall Street analysts covering Avantor, Inc. hold a median 12-month price target of $17 — +14.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 83 of 100 as at 21 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Avantor, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (87): The share count has been shrinking and the company is not leaning on new borrowing.
Quality (49): Profits are thin or unreliable for the size of the business, or they are not turning into cash.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
AVTR stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on AVTR, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +14.6% from it.
Of the 20 most recent actions, 15 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 29 Oct 2026 | Baird | Maintains | Outperform | $17 → $18 |
| 29 Oct 2026 | Barclays | Maintains | Underweight | $15 → $16 |
| 29 Oct 2026 | RBC Capital | Maintains | Sector Perform | $14 → $17 |
| 29 Oct 2026 | Stifel | Maintains | Hold | $15 → $18 |
| 13 Oct 2026 | Morgan Stanley | Maintains | Equal-Weight | $14 → $15 |
| 13 Oct 2026 | TD Cowen | Maintains | Hold | $15 → $17 |
| 7 Oct 2026 | Barclays | Maintains | Underweight | $13 → $15 |
| 9 Sept 2026 | UBS | Maintains | Neutral | $11 → $16 |
| 30 July 2026 | Evercore ISI Group | Maintains | In-Line | $11 → $14 |
| 30 July 2026 | Morgan Stanley | Maintains | Equal-Weight | $10 → $14 |
| 30 July 2026 | RBC Capital | Maintains | Sector Perform | $9.00 → $14 |
| 30 July 2026 | Stifel | Maintains | Hold | $8.00 → $15 |
| 30 July 2026 | Wells Fargo | Maintains | Overweight | $14 → $16 |
| 8 July 2026 | Citigroup | Maintains | Neutral | $9.00 → $11 |
| 6 July 2026 | Evercore ISI Group | Maintains | In-Line | $8.00 → $11 |
| 26 June 2026 | Bernstein | Reinstates | Market Perform | $11 |
| 24 June 2026 | Barclays | Maintains | Underweight | — |
| 2 June 2026 | Wolfe Research | Assumes | Underperform | $7.00 |
| 15 May 2026 | RBC Capital | Reinstates | Sector Perform | $9.00 |
| 30 Apr 2026 | Citigroup | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for AVTR.
This page is one stock. Monday covers all of them.
AVTR appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
AVTR vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Avantor, Inc. returned +35.0% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
AVTR analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 29.7×
- Price / sales
- 1.5×
- Price / book
- 1.7×
- EV / EBITDA
- 14.0×
Cheaper than 29% of US stocks
Cheaper than 55% of US stocks
Cheaper than 49% of US stocks
Cheaper than 38% of US stocks
- Revenue growth (YoY)
- 4.6%
- Earnings growth (YoY)
- —
- Gross margin
- 31.7%
- Operating margin
- 8.0%
- Net margin
- —
Higher than 39% of US stocks
Higher than 37% of US stocks
Higher than 59% of US stocks
- Return on equity
- 5.9%
- Return on assets
- 2.8%
- Dividend yield
- —
Higher than 54% of US stocks
Higher than 63% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Avantor, Inc. has a market value of $10.1B and an enterprise value of $13.3B.
Revenue in the twelve months to 30 June 2026: $6.6B. The latest quarter grew 0.5% year on year.
Net income over the same four quarters: −$578.0M, a −8.8% net margin.
Diluted earnings per share, trailing twelve months: −$0.84.
Free cash flow in the twelve months to 30 June 2026: $454.7M, after $142.3M of capital spending.
Avantor, Inc. spent $79.6M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 29.7×; forward P/E: 16.7× — the forward figure prices analyst consensus estimates, not reported earnings.
Avantor, Inc. employs 13,500 people — $486K of revenue per employee.
Data provided by Twelve Data
AVTR and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at AVTR’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Avantor, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about AVTR
What is the AVTR stock price forecast for 2026-2027?
The 15 Wall Street analysts covering Avantor, Inc. have a median 12-month price target of $17, with estimates ranging from $16 to $19. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is AVTR stock a buy right now?
Of the 15 analysts covering Avantor, Inc., 2 rate it a Buy, 12 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Avantor, Inc. 83 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank AVTR?
As at 21 Nov 2026, Avantor, Inc. ranks 83 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Issuance (87 of 100).
Will AVTR stock go up?
No one can know that. What the data says: the median 12-month target from 15 analysts implies +14.6% from the last close, and Ticker Nerd's factor model ranks Avantor, Inc. 83 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the AVTR stock forecast for 2030?
No analyst covering Avantor, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AVTR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $16 to $19 over the next 12 months.
How has AVTR stock performed over the past year?
Avantor, Inc. returned +35.0% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Avantor, Inc. do?
Avantor, Inc. is a global life science tools and advanced technology company that supplies mission-critical products and services to customers in biopharma, healthcare, education and government, and applied materials industries. Its portfolio includes laboratory chemicals, reagents, consumables, equipment, instrumentation, single-use bioprocessing components, and specialty services that support research, development, production, and quality control.
About Avantor, Inc.
Avantor, Inc. is a global life science tools and advanced technology company that supplies mission-critical products and services to customers in biopharma, healthcare, education and government, and applied materials industries. Its portfolio includes laboratory chemicals, reagents, consumables, equipment, instrumentation, single-use bioprocessing components, and specialty services that support research, development, production, and quality control. The company also provides customized materials and procurement solutions for highly regulated environments, helping laboratories and production teams maintain consistent workflows across the scientific supply chain. Avantor serves customers across the Americas, Europe, Asia, the Middle East, and Africa, with operations centered in Radnor, Pennsylvania.
CEO Mr. Emmanuel Ligner · 13,500 employees · United States · https://www.avantorsciences.com